Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Komaldeep, Kaur"'
Publikováno v:
Lung India, Vol 41, Iss 4, Pp 259-264 (2024)
Background Defensins are key effector molecules of innate immunity that can contribute towards the diagnosis and monitoring of chronic obstructive pulmonary disease (COPD). The present study was conducted to investigate the role of alpha-defensins in
Externí odkaz:
https://doaj.org/article/58bc2d8470e04dd88551dc6a8092abb9
Autor:
Amrutha S, Komaldeep Kaur, Deepak Aggarwal, Mandeep Kaur Sodhi, Shivani Jaswal, Varinder Saini
Publikováno v:
Monaldi Archives for Chest Disease (2023)
On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. According to the findings of various studies conducted around the world, the serological response varies greatly among different populations, with the determinants o
Externí odkaz:
https://doaj.org/article/493a948e3a4e4b739806f7450126fea7
Autor:
Sumit Sohal, Sheetal Vasundara Mathai, Sanjana Nagraj, Krishna Kurpad, Kandarp Suthar, Harsh Mehta, Komaldeep Kaur, Najam Wasty, Sergio Waxman, Marc Cohen, Gautam K. Visveswaran, Rajiv Tayal
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 10, p 331 (2022)
Background: Large bore access procedures rely on vascular closure devices to minimize access site complications. Suture-based vascular closure devices (S-VCD) such as ProGlide and ProStar XL have been readily used, but recently, newer generation coll
Externí odkaz:
https://doaj.org/article/c46c921428d24bfeb64f9ad8c65ecd4c
Publikováno v:
Monaldi Archives for Chest Disease (2021)
Mediastinal lymphadenopathy is often associated with tuberculosis, especially in a high burden country like India. We present a case of an asymptomatic female, who had mediastinal lymphadenopathy and middle lobe collapse, both of which pointed toward
Externí odkaz:
https://doaj.org/article/17c207781f8a48f0a5902697dc087578
Autor:
Monika Bansal, Komaldeep Kaur, Aditi Gupta, Deepak Goyal, Nidhi Girdhar, Vishal Chopra, Sanjeev Bhagat, Akhil D. Goel
Publikováno v:
Monaldi Archives for Chest Disease (2021)
Allergic rhinitis (AR) is a chronic allergen specific, IgE-mediated hypersensitivity disorder which significantly impairs the quality of life in affected patients. Many aeroallergens and molds are responsible for AR. This study was conducted to find
Externí odkaz:
https://doaj.org/article/c0743468205d457ca290648ac1606f88
Publikováno v:
Monaldi Archives for Chest Disease, Vol 90, Iss 4 (2020)
Pleural effusion is rarely encountered in patients of allergic bronchopulmonary aspergillosis (ABPA). We report the case of a 17-year-old male who presented with complaints of fever, cough and increasing shortness of breath for 3 weeks. Patient had b
Externí odkaz:
https://doaj.org/article/184341ce44a444b4ba01577882b421a6
Publikováno v:
Indian Journal of Tuberculosis. 69:669-674
Background Drug resistant tuberculosis (DR-TB), particularly multidrug resistance (MDR-TB) and extensive drug resistance (XDR-TB) pose a serious threat to public health. This study aimed to identify drug resistance in pulmonary tuberculosis patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3df31fa9fc8b3810578bd6513a5c68
https://doi.org/10.1016/j.ijtb.2021.10.003
https://doi.org/10.1016/j.ijtb.2021.10.003
Autor:
Goonja, Patel, Sachi, Singhal, Komaldeep, Kaur, Pooja, Jotwani, Ross, Budziszewski, Courtney, Fay
Publikováno v:
Cureus.
Coronavirus disease 2019 (COVID-19) impacted those with chronic diseases worldwide, especially those with diabetes. Very few studies have explored the effect of COVID-19 on diabetic patients' health markers. The present retrospective study compared v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c50fe322cf1622dbeceb24962be75687
https://doi.org/10.7759/cureus.30477
https://doi.org/10.7759/cureus.30477
Publikováno v:
Pneumon. 35:1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1934353ea8ba236f5374c3d8377662ec
https://doi.org/10.18332/pne/146642
https://doi.org/10.18332/pne/146642
Publikováno v:
Journal of the Endocrine Society. 6:A396-A397
SGLT2-inhibitors have revolutionized treatment for Type II diabetes (T2DM) due to their numerous benefits including improved glycemic control, cardioprotective properties, reduction of high blood pressure, and mitigation of disease progression in CKD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c26878687ec9ce54d445d8fded91c53
https://doi.org/10.1210/jendso/bvac150.825
https://doi.org/10.1210/jendso/bvac150.825